Travis Stracker: “We want to understand how genomic instability causes diseases such as cancer”
The video series Meet Our Scientists presents Travis Stracker, head of the Genomic Instability and Cancer lab at IRB Barcelona.
The video “Maintaining stability of the genome” highlights the research underway to unravel how cells prevent genomic instability.
The research performed by biologist Travis Stracker (Cleveland, OH, USA, 1974), head of the Genomic Instability and Cancer lab at IRB Barcelona, focuses on understanding of how cells prevent the accumulation of genomic instability.
This instability is caused by the accumulation of unrepaired mutations and errors in chromosomes. DNA damage occurs during each cell division or through exposure to exogenous agents, such as solar radiation, and chemical substances, such as tobacco smoke.
Stracker studies how cells prevent the accumulation of genomic instability by identifying the basic mechanisms that maintain the genome: “We have a genome consisting of millions of base pairs and it’s so delicate and susceptible: one mistake in the wrong place can have severe consequences.
In addition, his team studies how genomic instability influences cancer and rare diseases such as microcephaly. Stracker believes that his findings may be able to help provide patients with better treatments in the future.
Creativity, music and science
Barcelona is a great place in which to do research, says the scientist, who is very happy to be living in a city that inspires creativity. In this regard, he thinks that there are parallels between music and science, saying “in both we have to work well as a team, depending on the individual talents of each of the group members, and we have to use creativity and improvisation in order to tackle challenging questions”.
Stracker shows the music tapes that his friends have given him over the years that reflect how far technology has progressed. “I look forward to seeing what the next 25 years bring in terms of technological development”, he says.
"Meet Our Scientists" is a series of short videos that presents the group leaders at IRB Barcelona. The videos seek to showcase the vision, passion, character and talent of the scientists working at the centre, as well as to disseminate biomedical research.
This video has been supported by the Spanish Foundation of Science and Technology (FECYT) and the Ministry of Economy and Competitiveness.
Related content
News
These proteins are a potential therapeutic target for enhancing the effect of some cancer treatments.
Inhibition of TLK proteins triggers the Alternative Lengthening of Telomeres pathway, a common process in some of the most aggressive types of cancer, such as glioblastoma.
The study, performed by the Genomic Instability and Cancer Laboratory at IRB Barcelona, has been published in the journal Cell Reports.
The mechanism unveiled triggers a mutation fog, causing hundreds of mutations in each tumor, which spread through the genome of lung, head-and-neck and breast cancers.
Researchers from the Genome Data Science Lab have identified the antiviral APOBEC3A enzyme as the major cause of this new type of hypermutation.
Published in Nature Genetics, the study shows how the mutation fog process generates many oncogenic “cancer driver” mutations, thus accelerating tumour development.
Researchers at IRB Barcelona discover a new mechanism in estrogen receptor-positive breast cancer cells.
The inhibition of CPEB2, a key factor in the estrogen signalling pathway, causes cancer cells to proliferate less and protects mice against luminal breast cancer.
- Trustees:
-
- Center:
- A member of:
- Recognised by:
